Skip to Content
Merck
CN
  • STAT3 induces colorectal carcinoma progression through a novel miR-572-MOAP-1 pathway.

STAT3 induces colorectal carcinoma progression through a novel miR-572-MOAP-1 pathway.

OncoTargets and therapy (2018-06-27)
Nan Wang, Xianli He, Ru Zhou, Guozhan Jia, Qing Qiao
ABSTRACT

Colorectal carcinoma (CRC) is among the most common causes of death. Recent studies have shown that both STAT3 and miR-572 contribute to CRC progression. STAT3 plays an important role in miRNA expression. Moreover, MOAP-1, which is a pro-apoptotic protein that induces cell death or apoptosis, has a direct correlation with miRNA. Therefore, the current study is designed to explore whether miR-572 and STAT3 are involved in a common pathway and the role of MOAP-1 in this process. The expressions of STAT3, miR-572, and MOAP-1 in human CRC tissues and multiple cell lines were estimated by qRT-PCR or Western blot. MTT, transwell migration, and invasion assays were used to assess cell growth, migration, and invasion, respectively. Dual-luciferase reporter assay was applied to examine the association between miR-572 and MOAP-1. Elevated STAT3 levels were accompanied by increased miR-572 and decreased MOAP-1 levels in primary CRC specimens and cell lines. STAT3 promoted CRC cell growth, migration, and invasion via the upregulated expression of miR-572. Subsequently, miR-572 inhibited MOAP-1 protein expression through an interaction with its 3'UTR. Our study proposes a novel STAT3-miR-572-MOAP-1 pathway involved in the process of CRC progression, which might be a potential target for the development of new preventive and therapeutic approaches against human colorectal cancer.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-MOAP1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution